Limits...
Negative cooperativity across β1-adrenoceptor homodimers provides insights into the nature of the secondary low-affinity CGP 12177 β1-adrenoceptor binding conformation.

Gherbi K, May LT, Baker JG, Briddon SJ, Hill SJ - FASEB J. (2015)

Bottom Line: At the β1-adrenoceptor, CGP 12177 potently antagonizes agonist responses at the primary high-affinity catecholamine conformation while also exerting agonist effects of its own through a secondary low-affinity conformation.These effects on the BODIPY-TMR-CGP dissociation rate were markedly enhanced in β1-adrenoceptor homodimers constrained by bimolecular fluorescence complementation (9.8- and 9.9-fold for 1 µM CGP 12177 and 1 µM propranolol, respectively) and abolished in β1-adrenoceptors containing TM4 mutations vital for the second conformation pharmacology.This study suggests that negative cooperativity across a β1-adrenoceptor homodimer may be responsible for generating the low-affinity pharmacology of the secondary β1-adrenoceptor conformation.

View Article: PubMed Central - PubMed

Affiliation: Cell Signalling Research Group, School of Life Sciences, University of Nottingham, Nottingham, United Kingdom.

Show MeSH

Related in: MedlinePlus

Cooperative interactions between BODIPY-TMR-CGP and CGP 12177 and propranolol in bimolecular fluorescence complementation-constrained β1-adrenoceptor dimers. Dissociation of 3 nM BODIPY-TMR-CGP was measured under ID conditions every 2 s (shown every 6 s for better visualization). A) Normalized dissociation of 3 nM BODIPY-TMR-CGP in CHO-K1 cells transiently expressing wild-type (β1YFPN/β1YFPC) BiFC-constrained β1-adrenoceptor homodimers under ID conditions in the absence (n = 5) and presence of 1 μM CGP 12177 (n = 6) and 1 μM propranolol (n = 6). B) Normalized dissociation of 3 nM BODIPY-TMR-CGP in CHO-K1 cells transiently expressing 1 wild-type and 1 nonligand-binding (β1YFPN/β1D138AYFPC) protomer in BiFC-constrained β1-adrenoceptor homodimers under ID conditions in the absence (n = 5) and presence of 1 μM CGP 12177 (n = 6) and 1 μM propranolol (n = 5). Data were normalized to the fluorescence intensity level measured before initiation of imaging buffer only perfusion and show means ± sem of the indicated n separate experiments. Each experimental replicate reflects the average fluorescent intensity of the plasma membrane of 10 cells.
© Copyright Policy - creative-commons
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4478806&req=5

Figure 9: Cooperative interactions between BODIPY-TMR-CGP and CGP 12177 and propranolol in bimolecular fluorescence complementation-constrained β1-adrenoceptor dimers. Dissociation of 3 nM BODIPY-TMR-CGP was measured under ID conditions every 2 s (shown every 6 s for better visualization). A) Normalized dissociation of 3 nM BODIPY-TMR-CGP in CHO-K1 cells transiently expressing wild-type (β1YFPN/β1YFPC) BiFC-constrained β1-adrenoceptor homodimers under ID conditions in the absence (n = 5) and presence of 1 μM CGP 12177 (n = 6) and 1 μM propranolol (n = 6). B) Normalized dissociation of 3 nM BODIPY-TMR-CGP in CHO-K1 cells transiently expressing 1 wild-type and 1 nonligand-binding (β1YFPN/β1D138AYFPC) protomer in BiFC-constrained β1-adrenoceptor homodimers under ID conditions in the absence (n = 5) and presence of 1 μM CGP 12177 (n = 6) and 1 μM propranolol (n = 5). Data were normalized to the fluorescence intensity level measured before initiation of imaging buffer only perfusion and show means ± sem of the indicated n separate experiments. Each experimental replicate reflects the average fluorescent intensity of the plasma membrane of 10 cells.

Mentions: We then examined the dissociation rate of 3 nM BODIPY-TMR-CGP at irreversibly constrained stable wild-type/wild-type β1-adrenoceptor homodimers under ID conditions, which was determined to be 0.02 ± 0.01 min−1 (n = 5; Fig. 9A). This was significantly slower than the dissociation rate measured in CHO-β1 cells (P < 0.05, 2-way ANOVA analysis followed by Tukey’s multiple comparisons test). The dissociation of 3 nM BODIPY-TMR-CGP binding was enhanced in the presence of 1 µM CGP 12177 and 1 µM propranolol with dissociation rates of 0.186 ± 0.008 (n = 6) and 0.189 ± 0.007 min−1 (n = 6), respectively (Fig. 9A). This was significantly faster than the dissociation rate determined in the absence of unlabeled ligands (P < 0.05, 2-way ANOVA followed by Tukey’s multiple comparisons test; Fig. 9A). The change in the 3 nM BODIPY-TMR-CGP dissociation rate in the absence and presence of unlabeled ligands was ∼2-fold in CHO-β1 cells but was ∼10-fold in CHO-K1 cells expressing β1YFPN/β1YFPC homodimers.


Negative cooperativity across β1-adrenoceptor homodimers provides insights into the nature of the secondary low-affinity CGP 12177 β1-adrenoceptor binding conformation.

Gherbi K, May LT, Baker JG, Briddon SJ, Hill SJ - FASEB J. (2015)

Cooperative interactions between BODIPY-TMR-CGP and CGP 12177 and propranolol in bimolecular fluorescence complementation-constrained β1-adrenoceptor dimers. Dissociation of 3 nM BODIPY-TMR-CGP was measured under ID conditions every 2 s (shown every 6 s for better visualization). A) Normalized dissociation of 3 nM BODIPY-TMR-CGP in CHO-K1 cells transiently expressing wild-type (β1YFPN/β1YFPC) BiFC-constrained β1-adrenoceptor homodimers under ID conditions in the absence (n = 5) and presence of 1 μM CGP 12177 (n = 6) and 1 μM propranolol (n = 6). B) Normalized dissociation of 3 nM BODIPY-TMR-CGP in CHO-K1 cells transiently expressing 1 wild-type and 1 nonligand-binding (β1YFPN/β1D138AYFPC) protomer in BiFC-constrained β1-adrenoceptor homodimers under ID conditions in the absence (n = 5) and presence of 1 μM CGP 12177 (n = 6) and 1 μM propranolol (n = 5). Data were normalized to the fluorescence intensity level measured before initiation of imaging buffer only perfusion and show means ± sem of the indicated n separate experiments. Each experimental replicate reflects the average fluorescent intensity of the plasma membrane of 10 cells.
© Copyright Policy - creative-commons
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4478806&req=5

Figure 9: Cooperative interactions between BODIPY-TMR-CGP and CGP 12177 and propranolol in bimolecular fluorescence complementation-constrained β1-adrenoceptor dimers. Dissociation of 3 nM BODIPY-TMR-CGP was measured under ID conditions every 2 s (shown every 6 s for better visualization). A) Normalized dissociation of 3 nM BODIPY-TMR-CGP in CHO-K1 cells transiently expressing wild-type (β1YFPN/β1YFPC) BiFC-constrained β1-adrenoceptor homodimers under ID conditions in the absence (n = 5) and presence of 1 μM CGP 12177 (n = 6) and 1 μM propranolol (n = 6). B) Normalized dissociation of 3 nM BODIPY-TMR-CGP in CHO-K1 cells transiently expressing 1 wild-type and 1 nonligand-binding (β1YFPN/β1D138AYFPC) protomer in BiFC-constrained β1-adrenoceptor homodimers under ID conditions in the absence (n = 5) and presence of 1 μM CGP 12177 (n = 6) and 1 μM propranolol (n = 5). Data were normalized to the fluorescence intensity level measured before initiation of imaging buffer only perfusion and show means ± sem of the indicated n separate experiments. Each experimental replicate reflects the average fluorescent intensity of the plasma membrane of 10 cells.
Mentions: We then examined the dissociation rate of 3 nM BODIPY-TMR-CGP at irreversibly constrained stable wild-type/wild-type β1-adrenoceptor homodimers under ID conditions, which was determined to be 0.02 ± 0.01 min−1 (n = 5; Fig. 9A). This was significantly slower than the dissociation rate measured in CHO-β1 cells (P < 0.05, 2-way ANOVA analysis followed by Tukey’s multiple comparisons test). The dissociation of 3 nM BODIPY-TMR-CGP binding was enhanced in the presence of 1 µM CGP 12177 and 1 µM propranolol with dissociation rates of 0.186 ± 0.008 (n = 6) and 0.189 ± 0.007 min−1 (n = 6), respectively (Fig. 9A). This was significantly faster than the dissociation rate determined in the absence of unlabeled ligands (P < 0.05, 2-way ANOVA followed by Tukey’s multiple comparisons test; Fig. 9A). The change in the 3 nM BODIPY-TMR-CGP dissociation rate in the absence and presence of unlabeled ligands was ∼2-fold in CHO-β1 cells but was ∼10-fold in CHO-K1 cells expressing β1YFPN/β1YFPC homodimers.

Bottom Line: At the β1-adrenoceptor, CGP 12177 potently antagonizes agonist responses at the primary high-affinity catecholamine conformation while also exerting agonist effects of its own through a secondary low-affinity conformation.These effects on the BODIPY-TMR-CGP dissociation rate were markedly enhanced in β1-adrenoceptor homodimers constrained by bimolecular fluorescence complementation (9.8- and 9.9-fold for 1 µM CGP 12177 and 1 µM propranolol, respectively) and abolished in β1-adrenoceptors containing TM4 mutations vital for the second conformation pharmacology.This study suggests that negative cooperativity across a β1-adrenoceptor homodimer may be responsible for generating the low-affinity pharmacology of the secondary β1-adrenoceptor conformation.

View Article: PubMed Central - PubMed

Affiliation: Cell Signalling Research Group, School of Life Sciences, University of Nottingham, Nottingham, United Kingdom.

Show MeSH
Related in: MedlinePlus